One name is behind two major sales in spine medtech in 2025.
Investment firm Viscogliosi Brothers purchased key spinal assets from Stryker and Xtant Medical. Stryker sold its U.S. spine business, and Viscogliosi Brothers is using those assets to form VB Spine.
For Stryker the decision to sell the U.S. spine segment was over performance challenges, CEO Kevin Lobo said. Mr. Lobo said the sale will put the business in the hands of new owners with extensive experience in the spine market and allow Stryker to better align its resources.
Meanwhile Xtant Medical’s $19.2 million sale of certain Coflex and CoFix spinal implants and all OUS entities of Paradigm Spine GmbH to Companion Spine comes from plans to pivot into an orthobiologics focus.
When the deal closes, Xtant Medical’s spine assets will go to Companion Spine, which is a portfolio company of Viscogliosi Brothers.
